Company intelligence / Profile preview

GLOBIS

Chiyoda-ku, Tokyo, Japanglobis.com ↗

Ownership: Private
Development stage: Other

Overview

GLOBIS is Japan’s largest business school and an influential provider of MBA programs, corporate training, and venture capital investments. While its venture arm invests in technology—including healthcare and biotech startups—GLOBIS itself does not develop therapeutics or medical technologies directly.

Industry: Academic Hospital/University/Research

Partnerships

Investments via its VC arm in various Japanese startups across tech—including some healthcare/biotech—but no direct pharma partnerships listed

Beyond the preview

Go deeper on GLOBIS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GLOBIS.

Explore the full profile